BIO INX and Carl Roth partner to expand access to 3D bioprinting solutions

BIO INX, a leader in advanced bioinks for 3D bioprinting, and Carl Roth, a trusted name in research chemicals and laboratory supplies, have announced a new distribution agreement. This collaboration marks Carl Roth’s first foray into the 3D bioprinting space, as the company continues its strategy of expanding into the rapidly growing 3D printing industry. 

Through this partnership, Carl Roth will now offer BIO INX’s entire portfolio of bioinks, making these cutting-edge materials more accessible to researchers and scientists worldwide. This milestone enables Carl Roth to complement its existing 3D printing portfolio with innovative solutions tailored for tissue engineering, regenerative medicine, and other bioprinting applications.

BIO INX’s bioinks are designed to meet the diverse needs of the scientific community, with products optimized for various light-based and extrusion bioprinting technologies. While also focussing on clinical translation for example by including GMP-like inks in their portfolio.

This collaboration with Carl Roth ensures researchers can benefit from efficient logistics and trusted support as they push the boundaries of scientific innovation. By combining Carl Roth’s distribution network with BIO INX’s expertise in biomaterials, the partnership aims to accelerate advancements in bioprinting for both research and clinical applications.

Jasper Van Hoorick, CEO of BIO INX, commented, "Every scientist is familiar with Carl Roth’s products, and their one-stop shop principle and this partnership brings our technology closer to clinical reality through more efficient logistics and trusted partnerships."

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>